↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$227KSold on the market
1Companies
Sep 24, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 202620:21 | Sep 23, 2026 | TBPHTheravance Biopharma, Inc. | SVP, COMM & MEDICAL AFFAIRS | D · To issuer | — | −213,476 | 0 | -100% | — | ||
| Sep 17, 202617:52 | Sep 15, 2026 | TBPHTheravance Biopharma, Inc. | SVP, COMM & MEDICAL AFFAIRS | S · Sell10b5-1 | $17.03 | −13,314 | 213,476 | -6% | −$227K | ||
| Aug 24, 202618:00 | Aug 20, 2026 | TBPHTheravance Biopharma, Inc. | SVP, COMM & MEDICAL AFFAIRS | F · Tax | $16.95 | −5,667 | 226,790 | -2% | $96K |